Back to Agenda
Session 10: Post-Approval Changes (CMC, Manufacturing, and Labeling)
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Application to combination products
- Device and drug changes made to products approved via PMA
- Device and drug changes made to products approved via NDA
Have an account?